Petros Syrris

Gower Street
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 94 publications

An Updated Evidence Assessment of the Genetic Causes of Dilated Cardiomyopathy.

An Updated Evidence Assessment of the Genetic Causes of Dilated Cardiomyopathy.

Journal: Circulation
Published: September 08, 2026

Dysregulated T Cell-Mediated Immunity Underlies Progression of Arrhythmogenic Right Ventricular Cardiomyopathy.

Dysregulated T Cell-Mediated Immunity Underlies Progression of Arrhythmogenic Right Ventricular Cardiomyopathy.

Journal: Circulation
Published: June 01, 2026

Hypertrophic cardiomyopathy: a genome-wide association meta-analysis and polygenic risk score.

Hypertrophic cardiomyopathy: a genome-wide association meta-analysis and polygenic risk score.

Journal: Journal of medical genetics
Published: May 13, 2026

Sex Differences in Cardiac Involvement in Adults With Myotonic Dystrophy Type 1: A Multicenter Study.

Sex Differences in Cardiac Involvement in Adults With Myotonic Dystrophy Type 1: A Multicenter Study.

Journal: JACC. Advances
Published: January 27, 2026

External validation of the DSP-Risk Score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy associated genetic variants.

External validation of the DSP-Risk Score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy associated genetic variants.

Journal: Heart rhythm
Published: January 15, 2026

Genotype Predicts Heart Failure Independent of LVEF, Peak VO2, and NT-proBNP Levels in Hypertrophic Cardiomyopathy.

Genotype Predicts Heart Failure Independent of LVEF, Peak VO2, and NT-proBNP Levels in Hypertrophic Cardiomyopathy.

Journal: JACC. Heart failure
Published: January 11, 2026

The Yield and Clinical Impact of Genetic Testing in Older Patients with Dilated Cardiomyopathy.

The Yield and Clinical Impact of Genetic Testing in Older Patients with Dilated Cardiomyopathy.

Journal: European journal of heart failure
Published: October 16, 2025

Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate-Effect Variants.

Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate-Effect Variants.

Journal: Circulation
Published: August 29, 2025

Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants.

Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants.

Journal: Circulation
Published: August 20, 2025

Diagnostic Criteria and Disease Staging for Desmoplakin Cardiomyopathy.

Diagnostic Criteria and Disease Staging for Desmoplakin Cardiomyopathy.

Journal: medRxiv : the preprint server for health sciences
Published: July 16, 2025

NAXCARE: a clinical outcome registry for Naxos disease and related cardiocutaneous syndromes.

NAXCARE: a clinical outcome registry for Naxos disease and related cardiocutaneous syndromes.

Journal: Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese
Published: April 10, 2025

Cardiomyopathy caused by mitochondrial DNA 4300A > G variant.

Cardiomyopathy caused by mitochondrial DNA 4300A > G variant.

Journal: European heart journal
Published: February 05, 2025
Showing 1-12 of 94

Last Updated: 09/26/2026